In the podcast Advances at Mass General Cancer Center, Dr. Miyamoto discusses our recent paper in Cancer Discovery on using a digital RNA analysis of CTCs to predict treatment outcomes in metastatic prostate cancer and early dissemination in localized prostate cancer.
